We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Everybody needs a cheerleader to get a kidney transplant: a qualitative study of the patient barriers and facilitators to kidney transplantation in the Southeastern United States
BMC Nephrologyvolume 17, Article number: 108 (2016)
Kidney transplantation (KTx) disparity is a significant problem in the United States, particularly in the Southeastern region. In response to this phenomenon, the Southeastern Kidney Transplant Coalition was created in 2011 to increase the KTx rate, and to reduce disparities in access to transplantation in the Southeast, by identifying and reducing barriers in the transplant process.
To determine perceived barriers and facilitators to KTx that dialysis patients in this region experience, we conducted three focus groups with 40 total patients in Georgia, North Carolina, and South Carolina.
We identified two novel themes specific to Southeastern dialysis patients that describe the major barriers and facilitators to kidney transplantation: dialysis center approaches to patient education about KTx, and dialysis center advocacy and encouragement for KTx. In addition, themes related to barriers and facilitators of KTx were evident that were previously mentioned in the literature such as age, fear, knowing other patients with good or bad experiences with KTx, distrust of the KTx process equity, financial concerns and medical barriers.
Dialysis providers are encouraged to enhance their delivery of information and active assistance to underserved patients related to KTx.
Despite the known benefits of kidney transplantation (KTx), some patients with End Stage Renal Disease (ESRD) who are medically eligible, adequately insured, and interested in transplant struggle to get a transplant [1–4]. This is particularly the case for underserved patients, including minorities, older adults, and women [5–7]. In the Southeastern United States, kidney transplant disparity is particularly significant among African American patients who comprise 67 % of the prevalent ESRD population; yet, the KTx rate for this population is the lowest in the country [8–10]. In response to this phenomenon, in 2010 the Southeastern Kidney Transplant Coalition was created by the Southeastern Kidney Council (End Stage Renal Disease Network 6), to increase the KTx rate in this region by identifying and reducing barriers in the KTx process. This coalition is composed of more than 40 interdisciplinary members of the kidney community representing patients, dialysis companies, dialysis and KTx team members, transplant centers, organ procurement organizations, kidney patient advocacy organizations, and other stakeholders  and began work to identify KTx barriers through literature reviews, stakeholder meetings and strategic planning.
Previous research across the US has linked inadequate patient education and information [12, 13], poor provider communication  or education about KTx [15, 16], patient difficulty navigating the pathway to KTx , and environmental and social factors [8, 17–19] as barriers to underserved patients receiving a KTx. As robust as the existing literature is in this area, there has not yet been any qualitative exploration of patient-identified barriers of kidney transplant in the region that has the greatest kidney transplant disparity in the country -- the Southeast. The composition of the patient population in this region is significantly different than the rest of the United States, with more African Americans and a higher prevalence of ESRD combined with greater rates of poverty, chronic illness and the fewest KTx centers in the country . To inform the coalition’s patient-centered intervention planning and address the gap in the literature related to patient-centered insight about KTx in the Southeastern United States, we conducted three kidney patient focus groups in Georgia, North Carolina, and South Carolina (the three states comprising ESRD Network 6) to get patient feedback about their perceived barriers and facilitators to KTx.
In 2012, we conducted a qualitative study of patients on dialysis in Atlanta, Georgia; Columbia, South Carolina; and Greensboro, North Carolina using focus group methodology [20, 21] that has been previously used with patients with kidney disease [22, 23]. A convenience sample of forty total adult participants was recruited from attendees at an educational event hosted by the National Kidney Foundation in each of those cities. As this was a convenience sample (i.e. event participants were asked if they wanted to participate in the group), the inclusionary criteria for participants were that they were on dialysis and spoke English. Each focus group was 90 min in length, and participants also completed an optional brief anonymous survey to determine patient demographics and interest in KTx. The focus groups were anonymous, and patients did not share their names or identify the dialysis units where they received treatment.
The group moderators used an interview guide  (see Additional file 1) the Coalition members created which included probes about patient interest in KTx as a treatment modality, concerns or barriers patients have about getting a KTx, and facilitators or ways that dialysis team members can help patients get KTx. Two authors facilitated each group. The moderators audiotaped and trained research assistants transcribed all group discussions.
Patients were eligible for the focus group if they spoke English, were on dialysis, and were willing and able to participate in the session. Forty total patients participated in the three focus groups in Georgia (n = 12), North Carolina (n = 9) and South Carolina (n = 9) and received a $20 gift card as incentive.
Nine independent coders conducted manual content analysis of the group transcripts by utilizing qualitative analysis techniques [20, 21, 24–28]. In addition to the authors, five trained research assistants coded all transcripts independently. The coders individually examined the details of the transcripts, initial coded the content for patterns, identified the major categories of the codes, and created relevant themes found in the transcripts  through the use of a constant comparison method , reviewing every line in the transcripts. After this initial analysis, the nine coders compared, discussed, and synthesized the findings and created a list of the final themes based on group consensus.
Twenty-nine participants (73 %) completed a brief optional demographic survey following the focus group sessions (see Table 1). Fourteen (48 %) of these were men and 25 (86 %) were African American. Of the 26 patients who noted the length of time they had been on dialysis, the majority (46 %) were on dialysis for more than 2 years. Seven patients (27 %) were on dialysis for 1–2 years and 27 % were on dialysis for less than 1 year. Almost half (48 %) of the participants who provided their age (n = 27) were between the ages of 50–59, and 41 % were 40–49 years old. Of the 29 participants who filled out the survey, 76 % indicated that they were interested in a KTx, and 66 % noted that they have not been referred to a KTx center for evaluation. Two themes unique to these dialysis patients that emerged from these focus groups were dialysis center approaches to patient education about KTx and dialysis center encouragement and assistance for KTx. In all three of the focus groups, themes related to barriers and facilitators of KTx were also discovered that were previously mentioned in the literature such as age, fear, knowing other patients with good or bad experiences with KTx , distrust of the KTx process equity [30, 31], financial concerns  and medical barriers .
Dialysis center approaches to patient education about kidney transplantation
A major barrier and facilitator to KTx that was mentioned several times in each focus group was information (or lack thereof) patients received from their dialysis team members about transplant, and how to get a KTx. The majority of patients agreed that they do not receive enough information about KTx from their dialysis teams, or that the information they do receive was often not helpful or pro forma. When asked about their current knowledge about KTx, one patient, who shared that he was on dialysis for 2 year, stated, “I just didn’t know…. I’m just not learning.” In a different focus group, a patient said that “we stay in a state of confusion, we don’t understand.” One patient in Georgia shared:
I’m a new dialysis patient and I know absolutely nothing about the transplant process or anything. At the clinic that I attend it’s kind of hush-hush. They don’t say anything about it.
Patients in all three states claimed they felt overwhelmed with information that dialysis teams give patients, and that information about KTx is not presented in a meaningful way, as one patient in South Carolina expressed:
Being sick we don’t really think as well as we used to, and they hit you with a lot of terms at once and all this. What we really need is someone who knows the system inside and out, they understand all the pieces and parts, to sit down with us and say you’ve got these 7 things done and these 7 things are not done…We don’t get that and…they’re withholding information. They just don’t give it to us.
Patients also claimed they felt overwhelmed with information or given information in a perfunctory manner, as one patient in North Carolina stated:
They show us a tape every year [about KTx] when we sit in the little lobby, and they pop that little tape in, and they say you need to watch this, and we don’t watch it because we sit in the lobby and talk. And then we go in the back [to the dialysis unit], and then they say, sign this piece of paper saying you saw the video. So we sign it. [They ask] “Did you understand all that you saw”? Yes we did. And you know, we don’t, we sitting out there talking about what we cooked, what the kids did, all the things but what’s actually going on on that video screen. We never saw it. But we lie when we get in the back and say yes, I did watch it. And they know that we didn’t watch it either.
Patients in all three groups agreed that they need more, and better, information and education from their dialysis centers about KTx. Patients verbalized an appreciation for information about KTx from their interdisciplinary dialysis teams. One patient summed up this sentiment by stating: “If you’re educated, you can make it through.”
Dialysis center encouragement and assistance
The second novel theme from these focus groups is the importance of advocacy and encouragement from dialysis team members related to KTx. As one individual summarized: “everybody needs a cheerleader” [to get a KTx]. Many patients in all three groups lamented that some dialysis professionals’ behaviors were a discouragement to pursuing KTx. As one participant shared:
When we started with the nephrologist, when we were first diagnosed with renal failure, and we went into the office and saw the nephrologist, we should have been given options then…when I came in to see her, she never introduced herself, she walked in the room and she said…we’re going to put you in the hospital today, we’re going to do a biopsy, we’re going to do, she said like twenty things. I said well…who are you? She said I’m Dr. so and so, I said interesting, I’m not doing any of that. You gonna need to rewind, go back out the door, come back in, tell me who you are, and then after you tell me who you are, let’s discuss my options. Because you not giving me a choice, so if you don’t give me a choice, well that doesn’t work for me, I don’t know about anybody else, I shut down. If I don’t have no hope, what’s the purpose in us doing this? If you told me I have the ability to have a transplant, and showed me my option for transplant then, oh we could have probably had a wonderful relationship, but to this day she don’t like me because it was ugly. When you walk in the door and you’re not giving your people the option [of KTx], and I’m, well anyway… when you are given no hope, transplant is hope. We’re not given that hope.
Conversely, patients in all three groups also identified characteristics of helpful dialysis professionals. They explained that having someone on the dialysis team who was empathetic, informative, and a patient advocate was essential in navigating the pathway to KTx. There was no consensus as to who on the dialysis team was most helpful—some patients said it was their physician; others stated it was their social worker, nurse, or patient care technician. Several different patients talked about having a designated team member who was responsible for helping patients get a KTx, and how that was very helpful. One patient explained how his nurse fulfills this role, stating, “I talk to her about it, you know, getting on the transplant list and what I had to do and she talked me through it and we went through the process.”
Another patient described how he felt because he did not have such an individual in his dialysis unit:
[It would be helpful]” just to have someone just inform you and talk to you about different options or, you know, just try and encourage you. You know, my first few years on dialysis was a disaster. I didn’t have nobody to talk to me, I didn’t have nobody, you know, I had my family but they don’t know.”
Many patients in each group expressed the belief that being a good self-advocate, and successfully managing their own care was a significant facilitator in pursuing a KTx. One patient summed up this theme by stating: “you have to be your own quarterback” when asked what patients could do to be successful in getting a KTx. The consensus from all three focus groups was that their dialysis centers needed to be more encouraging about KTx and give directed assistance so that patients can pursue KTx to augment patients’ self advocacy.
In all three of the focus groups, themes related to barriers and facilitators of KTx were discovered that were previously mentioned in the literature. A major component of these other barriers involved patient beliefs about distrusting the entire KTx process. When asked who they thought got kidney transplants, the majority of patients in the three groups responded that they believed individuals who were white and had a higher income, education, and status were more likely to get a KTx. This is exemplified by the following quotes from three different patients: “I always say the doctor don’t treat you right if you don’t have the right kind of insurance,” “I believe the one gets it [KTx] is who has the most money to pay for it,” and:
I think it has to do a lot with income, and not only just income, this is just something that I saw, you know on TV, you know, I don’t know if it’s true or not, but just based on some things that the individual is doing based on statistics and then there was a, uh, I don’t know if he was a football player or baseball player just recently diagnosed and you know, (snapping of the fingers) just like that, at the drop of a hat, he was able to get a transplant within a week.
This qualitative study allowed patients on dialysis in Georgia, North Carolina, and South Carolina to identify the barriers and facilitators to KTx that were most salient to them to inform further patient-centered research and help individuals in this region get a KTx. Although some of the findings from this study are similar to previous work, the participants in this study identified novel areas for interventions to promote or discourage KTx that can be useful in this region and beyond. This study is also unique in targeting patients in the Southeast, where KTx rates are the lowest in the nation, an essential first step in informing relevant interventions.
The current Centers for Medicaid and Medicare (CMS) Conditions for Coverage for End-Stage Renal Disease Facilities clearly mandate that all dialysis facilities should be providing patients with information and assistance related to KTx . Our finding that 76 % of focus group participants who completed their demographic forms were interested in KTx, but only 34 % had been referred to a transplant center for evaluation, is consistent with previous research conducted after the 2008 implementation of the Conditions for Coverage that suggests that despite these regulations, many patients on dialysis (particularly underserved populations) in the United States are interested in getting a kidney transplant but lack necessary information about kidney transplantation and how to get a kidney transplant [1, 2, 6, 33–37]. This qualitative study may help elucidate why this is happening in some dialysis units.
This work also suggests that providers can improve their patient-centered delivery of care related to KTx assistance. As the emphasis on patient-centered care [38–40] and shared decision making [38, 41] increases in health delivery systems in ESRD and beyond, dialysis providers may find some of the suggestions from the patients in our study helpful in their own quality assurance performance initiative projects, and researchers can build upon these findings in future intervention research. For example, dialysis units can provide patients with repeated and meaningful information and assistance related to KTx, and make sure that patients understand the education they receive. Furthermore, they may want to encourage patients’ abilities to better self-manage  their ESRD care and KTx pursuit so that patients can be their “own quarterbacks” and advocate for themselves more effectively. The patients who participated in these focus groups made it clear that it is not enough for dialysis providers to simply give out information about KTx. Patients want meaningful and active assistance with the transplant process. It is also critical to address patients’ distrust of the transplant process in order to help the most underserved patients.
There are several limitations to the study findings. Inherently, focus groups are limited by small sample size, discussions can be difficult to control, participants may not contribute equally to the discussion and the group moderator may impact participant responses because of the way the questions are delivered. In our study, the sample size is intentionally small in order to explore in-depth individual feelings and beliefs. We controlled the group and participation of all group members by only allowing one person to speak at a time, directly encouraging all members to participate, and “calling on” different patients to contribute so that a few patients did not dominate the conversation. We also only used questions from our interview guide to insure that the moderators did not influence the patient responses. Despite the possible limitations of focus groups, there are also many advantages to this research methodology. Focus groups allow for an in-depth exploration of opinion that is not possible in quantitative research and may be more inclusive as participants do not have to have the literacy and numeracy skills necessary to complete surveys or other methods of data collection.
The Georgia focus group with 12 patients is slightly larger than the 6–10 participants recommended , however that group did have two facilitators directing the conversation and all patients had an opportunity to share their feelings about the interview questions. Because the groups were entirely anonymous and no patient names were revealed or used, it may be that group rapport was diminished however each group had robust discussions involving all attendees. This research was conducted with a convenience sample of patients in only three states; these participants might not be typical patients on dialysis, in that they were motivated to attend a patient education event and participate in the focus group. In addition, as only one focus group was conducted in these three states, the patients in this study may not be representative of all patients in their state. Therefore, as with any qualitative research, the findings have limited generalizability even within the three states where this research occurred.
However, this information may be particularly useful for the Southeastern region of the US, which has dialysis facilities with the lowest KTx rates in the nation and cares for the most underserved patients . As this study was entirely anonymous and the investigators were not privy to the patient medical records, we have no way of knowing if the focus group patients would even be medically eligible and suitable for a KTx. Furthermore, our convenience sample was not exactly reflective of the demographic composition of Network 6 (e.g., in Network 6, 55 % prevalent patients are men and 67 % are African American. In this study 48 % of respondents who completed the survey were men and 86 % African American). However, we are encouraged that the findings are robust as they are congruent with previous quantitative research across the country and suggest that: (a) there is a sizeable portion of patients on dialysis who mistakenly believe that they are active on a KTx list, when in fact they are not [1, 33–37] and (b) that dialysis providers may not be effectively communicating with patients about KTx .
This study complements the growing body of international qualitative research with kidney disease and transplant patients, including studies that examine the development of patient education materials about KTx and other treatment options [43, 44]; issues related to living kidney donation [45, 46]; patient understanding of increased-risk donor kidneys [22, 47]; the experience of kidney transplant rejection ; donor-recipient relationships ; the kidney disease trajectory ; kidney disease research priorities  and kidney treatment options . This is the first study to specifically explore the patient-identified facilitators and barriers to seeking a KTx in the Southeastern United States.
Patient perceived barriers and facilitators to KTx are just one attribute contributing to KTx rates, in addition to other patient factors (i.e. medical and financial eligibility) as well as dialysis facility, geographical, and transplant center factors. These focus groups provide insight that can inform larger scale studies. Accordingly, the Southeastern Kidney Transplant Coalition has surveyed all dialysis units in the Network about their KTx practices [51, 52] and continues to conceptualize KTx referral success as dependent on multiple factors.
To our knowledge, this is the first study to specifically explore the patient-identified facilitators and barriers to seeking a KTx in the Southeastern United States. Because this study was conducted in the area with the highest concentration of African American patients receiving dialysis, the study may also be helpful to other ESRD networks that are now mandated by CMS to attend to ESRD disparities, including the promotion of KTx . The most important result of qualitative work such as this may be to remind the ESRD community, in the words of one of the focus group attendees, that “everybody needs a cheerleader” to get a KTx.
Browne T. The relationship between social networks and pathways to kidney transplant parity: Evidence from black Americans in Chicago. Soc Sci Med. 2011;73:663–7.
DePasquale N, Ephraim PL, Ameling J, et al. Selecting renal replacement therapies: what do African American and non-African American patients and their families think others should know? A mixed methods study. BMC Nephrol. 2013;14:14–9.
Evans K, Coresh J, Bash LD, et al. Race differences in access to health care and disparities in incident chronic kidney disease in the US. Nephrol Dial Transplant. 2011;26:899–908.
Johansen KL, Zhang R, Huang Y, et al. Association of race and insurance type with delayed assessment for kidney transplantation among patients initiating dialysis in the United States. Clin J Am Soc Nephrol. 2012;7:1490–7.
Patzer RE, Pastan SO. Measuring the disparity gap: quality improvement to eliminate health disparities in kidney transplantation. Am J Transplan. 2013;13:247–8.
Boulware LE, Hill-Briggs F, Kraus ES, et al. Effectiveness of educational and social worker interventions to activate patients’ discussion and pursuit of preemptive living donor kidney transplantation: a randomized controlled trial. Am J Kidney Dis. 2013;61:476–686.
Sullivan C, Leon JB, Sayre SS, et al. Impact of navigators on completion of steps in the kidney transplant process: a randomized, controlled trial. Clin J Am Soc Nephrol. 2012;7:1639–45.
Patzer RE, Amaral S, Wasse H, et al. Neighborhood poverty and racial disparities in kidney transplant waitlisting. J Am Soc Nephrol. 2009;20:1333–40.
Patzer RE, McClellan WM. Influence of race, ethnicity and socioeconomic status on kidney disease. Nat Rev Nephrol. 2012;8:533–41.
Patzer RE, Perryman JP, Schrager JD, et al. The role of race and poverty on steps to kidney transplantation in the southeastern United States. Am J Transplant. 2012;12:358–68.
Patzer RE, Pastan SO. Kidney transplant access in the Southeast: view from the bottom. Am J Transplant. 2014;14:1499–505.
Ayanian JZ, Cleary PD, Weissman JS, et al. The effect of patients’ preferences on racial differences in access to renal transplantation. N Engl J Med. 1999;341:1661–9.
Sheu J, Ephraim PL, Powe NR, et al. African American and Non-African American patients’ and families’ decision making about renal replacement therapies. Qual Health Res. 2012;22:997–1006.
Boulware LE, Meoni LA, Fink NE, et al. Preferences, knowledge, communication and patient-physician discussion of living kidney transplantation in African American families. Am J Transplant. 2005;5(6):1503–12.
Neyhart CD. Education of patients pre and post-transplant: improving outcomes by overcoming the barriers. Nephrol Nurs. 2008;35:409–10.
Waterman AD, Browne T, Waterman BM, et al. Attitudes and behaviors of African Americans regarding early detection of kidney disease. Am J Kidney Dis. 2008;51:554–62.
Hall YN, Choi AI, Xu P, et al. Racial and ethnic differences in rates and determinants of deceased donor kidney transplantation. J Am Soc Nephrol. 2011;22:743–51.
Hall Y, O’Hare A, Young B, et al. Neighborhood poverty and kidney transplantation among US Asians and Pacific Islanders with End‐Stage Renal Disease. Am J Transplant. 2008;8:2402–9.
Keith D, Ashby VB, Port FK, et al. Insurance type and minority status associated with large disparities in prelisting dialysis among candidates for kidney transplantation. Clin J Am Soc Nephrol. 2008;3:463–70.
Asbury JE. Overview of focus group research. Qual Health Res. 1995;5:414–20.
Morgan DL. Focus groups as qualitative research. Thousand Oaks: Sage Publications, Inc.; 1996.
Ros RL, Kucirka LM, Govindan P, et al. Patient attitudes toward CDC high infectious risk donor kidney transplantation: inferences from focus groups. Clin Transplant. 2012;26:247–53.
Schell JO, Patel UD, Steinhauser KE, et al. Discussions of the kidney disease trajectory by elderly patients and nephrologists: a qualitative study. Am J Kidney Dis. 2001;59:495–503.
Sofaer S. Qualitative research methods. Int J Qual Health Care. 2002;14:329–36.
Glaser BG, Strauss AL. The discovery of grounded theory: Strategies for qualitative research. Piscataway: Aldine Transaction; 1967.
Krueger RA, Casey MA. Focus groups: A practical guide for applied research. Thousand Oaks: Sage Publications, Inc.; 2008.
Saldaña J. The coding manual for qualitative researchers. Thousand Oaks: Sage Publications, Inc.; 2012.
Gordon EJ. Patients’ decisions for treatment of end-stage renal disease and their implications for access to transplantation. Soc Sci Med. 2001;53:971–87.
Navaneethan SD, Singh S. A systematic review of barriers in access to renal transplantation among African Americans in the United States. Clin Transplant. 2006;20:769–75.
Gillespie A, Hammer H, Lee J, et al. Lack of listing status awareness: results of a single‐center survey of hemodialysis patients. Am J Transplant. 2011;11:1522–6.
Martin SC, Stone AM, Scott AM, et al. Medical, personal, and social forms of uncertainty across the transplantation trajectory. Qual Health Res. 2010;20:182–96.
Federal Register. Conditions for Coverage for ESRD facilities, Vol 42 CFR Part 405, Subpart U. Washington, DC, U.S: GPO; 2008.
Morton RL, Tong A, Howard K, et al. The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies. BMJ. 2010;19:340–50.
Purnell TS, Hall YN, Boulware LE. Understanding and overcoming barriers to living kidney donation among racial and ethnic minorities in the United States. Adv Chronic Kidney Dis. 2012;19:244–51.
Waterman AD, Rodrigue JR, Purnell TS, et al. Addressing racial and ethnic disparities in live donor kidney transplantation: priorities for research and intervention. Semin Nephrol. 2012;30:90–8.
Lipkin M. Shared decision making: comment on “association of patient preferences for participation in decision making with length of stay and costs among hospitalized patients”. JAMA Intern Med. 2013;173:1195–205.
Reese PP, Nair M, Bloom RD. Eliminating racial disparities in access to living donor kidney transplantation: how can centers do better? Am J Kidney Dis. 2012;59:751–3.
Tong A, Wong G, McTaggart S, et al. Quality of life of young adults and adolescents with chronic kidney disease. J Pediatr. 2013;163:1179–85.
Gordon EJ, Butt Z, Jensen SE, et al. Opportunities for shared decision making in kidney transplantation. Am J Transplant. 2013;13:1149–58.
Browne T, Merighi JR. Barriers to adult hemodialysis patients’ self-management of oral medications. Am J Kidney Dis. 2010;56:547–57.
Weiner SJ, Schwartz A, Sharma G, et al. Patient-centered decision making and health care outcomes: an observational study. Ann Intern Med. 2013;158:573–9.
Patzer RE, Plantinga L, Krisher J, et al. Dialysis facility and network factors associated with low kidney transplantation rates among United States dialysis facilities. Am J Transplant. 2014;14:1562–72.
Wilson R, Brown DR, Boothe S, Weng FL. Improving the delivery of patient education about kidney transplant in a transplant center. Prog Transplant. 2012;22:403–12.
Ameling JM, Auguste P, Ephraim PL, et al. Development of a decision aid to inform patients’ and families’ renal replacement therapy selection decisions. BMC Med Inform Decis Mak. 2012;12:140.
Boulware LE, Hill-Briggs F, Kraus E, et al. Identifying and addressing barriers to African American and non–African American families’ discussions about preemptive living related kidney transplantation. Prog Transplant. 2011;21:97–105.
Waterman AD, Stanley SL, Covelli T, et al. Living donation decision making: recipients’ concerns and educational needs. Prog Transplant. 2006;16:17–23.
Gordon EJ, Reddy E, Ladner DP, et al. Kidney transplant candidates’ understanding of increased risk donor kidneys: a qualitative study. Clin Transplant. 2012;26:359–68.
Ouellette A, Achille M, Paquet M. The experience of kidney graft failure: Patients’ perspectives. Qual Health Res. 2009;19:1131–8.
Papachristou C, Walter M, Schmid G, et al. Living donor liver transplantation and its effect on the donor–recipient relationship – a qualitative interview study with donors. Clin Transplant. 2009;23:382–91.
Tong A, Sainsbury P, Carter SM, et al. Patients’ priorities for health research: focus group study of patients with chronic kidney disease. Neph Dialysis Transplant. 2008;23:3206–14.
Gander J, Browne T, Plantinga L, et al. Dialysis facility transplant philosophy and access to kidney transplantation in the Southeast. Am J Neph. 2015;41:504–11.
Browne T Amamoo MA Gander J, et al. Kidney transplant referral practices in Southeastern dialysis units. Clin Transplant. 2016;30:365–71.
The authors acknowledge the Southeastern Kidney Council and all of the members of the Southeastern Kidney Transplant Coalition for their significant assistance with this work, particularly the National Kidney Foundation of GA, NC & SC and the University of South Carolina research assistants who contributed to the data coding. The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
The authors disclosed receipt of the following financial support for the research, authorship, and or publication of this article: This work was supported in part by NIH NIDDK Award R15DK088707 (Browne) and NIH NIMHD Award R24MD008077 (Amamoo, Patzer & Pastan). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDDK, NIMHD or the NIH. The analyses upon which this publication is based were performed under Contract Number HHSM-500-2013-NW006C entitled End Stage Renal Disease Networks Organization for the State (Commonwealth) of GA, NC & SC, sponsored by the Centers for Medicare & Medicaid Services, Department of Health and Human Services. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The authors assume full responsibility for the accuracy and completeness of the ideas presented. This article is a direct result of the Health Care Quality Improvement Program initiated by the Centers for Medicare & Medicaid Services, which has encouraged identification of quality improvement projects derived from analysis of patterns of care, and therefore required no special funding on the part of this contractor. Ideas and contributions to the authors concerning experience in engaging with issues presented are welcomed. Dr. Pastan is a minority shareholder in Fresenius College Park Dialysis, College Park, Georgia.
TB participated in drafting the article. TB, AA and REP participated data collection, data analysis and interpretation. All authors participated in the concept and design of the study, in critical revision of article and approval of article.
The authors declare that they have no competing interests.
Consent for publication
Ethical approval and consent to participate
This study was approved by the institutional review boards of the University of South Carolina and Emory University. Written informed consent for participation in the study was obtained from all participants.
Focus Group Interview Guide. This is the interview guide used for all of the focus groups in this study. (DOCX 14 kb)